Euro A–BBB Healthcare & Pharmaceuticals Corporate Bond Yields (EUR)
Fitted spot curve as of 2026-07-27
https://bondscovery.com/yield-curve/eur-corporate-a-bbb-healthcare-pharmaceuticals
Euro A–BBB Healthcare & Pharmaceuticals Corporate Bond Yields (EUR) as of 2026-07-27: 10Y at 4.06%, fitted curve 3M–30Y (3.04%–4.85%), 46 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 3M | 3.04% | — |
| 6M | 3.07% | 3.10% |
| 18M | 3.18% | 3.24% |
| 2Y | 3.24% | 3.42% |
| 3Y | 3.36% | 3.59% |
| 4Y | 3.47% | 3.81% |
| 5Y | 3.58% | 4.02% |
| 6Y | 3.69% | 4.22% |
| 7Y | 3.79% | 4.40% |
| 8Y | 3.89% | 4.57% |
| 9Y | 3.98% | 4.71% |
| 10Y | 4.06% | 4.84% |
| 15Y | 4.41% | 5.11% |
| 20Y | 4.64% | 5.32% |
| 25Y | 4.77% | 5.32% |
| 30Y | 4.85% | 5.24% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 3.24% and the 10-year 4.06%, a 10Y−2Y spread of +82 bp — positively sloped — as of 2026-07-27. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-07-27 |
|---|---|
| 2Y | 3.24% |
| 10Y | 4.06% |
| 10Y − 2Y | +82 bp |
Bonds in this curve
A selection of 30 of the 47 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Fresenius SE & CO Kgaa | 2.87% | 2026-11-30 | 0.62% | XS2084497705 |
| Astrazeneca PLC | 2.96% | 2027-03-03 | 3.62% | XS2593105393 |
| Medtronic Global Holdings SCA | 2.59% | 2027-03-07 | 1.12% | XS1960678255 |
| GSK Capital BV | 3.08% | 2027-11-28 | 3.00% | XS2553817680 |
| Astrazeneca PLC | 2.73% | 2028-05-12 | 1.25% | XS1411404426 |
| Werfen SA/Spain | 3.67% | 2028-06-06 | 4.62% | XS2630465875 |
| Stryker Corp | 3.32% | 2028-12-11 | 3.38% | XS2732952838 |
| Astrazeneca PLC | 3.15% | 2029-06-03 | 0.38% | XS2347663507 |
| H. Lundbeck A/S | 3.70% | 2029-06-02 | 3.38% | XS3081808837 |
| Glaxosmithkline Capital | 3.13% | 2029-09-12 | 1.38% | XS1681520356 |
| Danaher Corporation | 3.42% | 2030-04-29 | 3.25% | XS3352082930 |
| Werfen SA/Spain | 3.81% | 2030-05-03 | 4.25% | XS2811962195 |
| Glaxosmithkline Capital | 3.33% | 2030-05-21 | 1.75% | XS1822829799 |
| Medtronic Global Holdings SCA | 3.43% | 2031-03-07 | 1.62% | XS1960678412 |
| Medtronic Global Holdings SCA | 3.49% | 2031-07-02 | 1.00% | XS2020670852 |
| Fresenius SE & CO Kgaa | 3.72% | 2031-07-08 | 3.38% | XS3435668325 |
| Werfen SA/Spain | 3.99% | 2032-02-12 | 3.62% | XS3090952519 |
| Astrazeneca PLC | 3.47% | 2032-03-03 | 3.75% | XS2593105476 |
| Eurofins Scientific SE | 4.16% | 2033-02-05 | 3.88% | XS3135157298 |
| Becton Dickinson & CO | 3.97% | 2033-05-20 | 3.85% | XS3368849348 |
| Danaher Corporation | 3.80% | 2034-04-29 | 3.62% | XS3352083409 |
| Fresenius SE & CO Kgaa | 4.05% | 2034-07-08 | 3.75% | XS3435670222 |
| Sandoz Finance B.V. | 4.04% | 2035-03-26 | 4.00% | XS3032013511 |
| GSK Capital BV | 3.85% | 2036-11-19 | 3.25% | XS2933692753 |
| Smith & Nephew PLC | 4.31% | 2038-06-03 | 4.25% | XS3384821834 |
| Medtronic Global Holdings SCA | 4.09% | 2039-03-07 | 2.25% | XS1960678685 |
| Medtronic Global Holdings SCA | 4.13% | 2039-07-02 | 1.50% | XS2020670936 |
| BMS Ireland Capital Funding DAC | 4.58% | 2045-11-10 | 4.29% | XS3215466502 |
| Medtronic Global Holdings SCA | 4.61% | 2049-07-02 | 1.75% | XS2020671157 |
| BMS Ireland Capital Funding DAC | 4.92% | 2055-11-10 | 4.58% | XS3215466767 |